Literature DB >> 31608518

A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotype.

Alfonsina Ballester-Lopez1,2, Emma Koehorst1, Miriam Almendrote1,3, Alicia Martínez-Piñeiro1,3, Giuseppe Lucente1,3, Ian Linares-Pardo1, Judit Núñez-Manchón1, Nicolau Guanyabens3, Antoni Cano4, Alejandro Lucia5,6, Gayle Overend7, Sarah A Cumming7, Darren G Monckton7, Teresa Casadevall8, Irina Isern9, Josep Sánchez-Ojanguren9, Albert Planas10, Agustí Rodríguez-Palmero1,11, Laura Monlleó-Neila1,11, Guillem Pintos-Morell1,2,12, Alba Ramos-Fransi1,3, Jaume Coll-Cantí1,2,3, Gisela Nogales-Gadea1,2.   

Abstract

Carriage of interruptions in CTG repeats of the myotonic dystrophy protein kinase gene has been associated with a broad spectrum of myotonic dystrophy type 1 (DM1) phenotypes, mostly mild. However, the data available on interrupted DM1 patients and their phenotype are scarce. We studied 49 Spanish DM1 patients, whose clinical phenotype was evaluated in depth. Blood DNA was obtained and analyzed through triplet-primed polymerase chain reaction (PCR), long PCR-Southern blot, small pool PCR, AciI digestion, and sequencing. Five patients of our registry (10%), belonging to the same family, carried CCG interruptions at the 3'-end of the CTG expansion. Some of them presented atypical traits such as very late onset of symptoms ( > 50 years) and a severe axial and proximal weakness requiring walking assistance. They also showed classic DM1 symptoms including cardiac and respiratory dysfunction, which were severe in some of them. Sizes and interrupted allele patterns were determined, and we found a contraction and an expansion in two intergenerational transmissions. Our study contributes to the observation that DM1 patients carrying interruptions present with atypical clinical features that can make DM1 diagnosis difficult, with a later than expected age of onset and a previously unreported aging-related severe disease manifestation.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Steinert disease; atypical symptoms; interruptions; late onset; myotonic dystrophy type 1; severe phenotype; variant repeats

Mesh:

Substances:

Year:  2019        PMID: 31608518     DOI: 10.1002/humu.23932

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

Review 1.  An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics.

Authors:  Sanjog R Chintalaphani; Sandy S Pineda; Ira W Deveson; Kishore R Kumar
Journal:  Acta Neuropathol Commun       Date:  2021-05-25       Impact factor: 7.801

2.  High throughput screening for expanded CTG repeats in myotonic dystrophy type 1 using melt curve analysis.

Authors:  Russell J Butterfield; Carina Imburgia; Katie Mayne; Tara Newcomb; Diane M Dunn; Brett Duval; Marcia L Feldkamp; Nicholas E Johnson; Robert B Weiss
Journal:  Mol Genet Genomic Med       Date:  2021-02-24       Impact factor: 2.183

3.  Identification, molecular characterization and segregation analysis of a variant DMPK pre-mutation allele in a three-generation Italian family.

Authors:  Luana Fontana; Massimo Santoro; Maria Rosaria D'Apice; Francesca Peluso; Giulia Gori; Amelia Morrone; Giuseppe Novelli; Laura Dosa; Annalisa Botta
Journal:  Acta Myol       Date:  2020-03-01

4.  Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1.

Authors:  Alfonsina Ballester-Lopez; Emma Koehorst; Ian Linares-Pardo; Judit Núñez-Manchón; Miriam Almendrote; Giuseppe Lucente; Andrea Arbex; Carles Puente; Alejandro Lucia; Darren G Monckton; Sarah A Cumming; Guillem Pintos-Morell; Jaume Coll-Cantí; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Gisela Nogales-Gadea
Journal:  Genes (Basel)       Date:  2020-11-07       Impact factor: 4.096

5.  Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of DMPK in Patients with Myotonic Dystrophy Type 1.

Authors:  Mathis Hildonen; Kirsten Lykke Knak; Morten Dunø; John Vissing; Zeynep Tümer
Journal:  Genes (Basel)       Date:  2020-08-13       Impact factor: 4.096

Review 6.  Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1.

Authors:  Stojan Peric; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic Stojanovic; Giovanni Meola
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 7.  Advancing genomic technologies and clinical awareness accelerates discovery of disease-associated tandem repeat sequences.

Authors:  Terence Gall-Duncan; Nozomu Sato; Ryan K C Yuen; Christopher E Pearson
Journal:  Genome Res       Date:  2021-12-29       Impact factor: 9.438

8.  Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1.

Authors:  Emma Koehorst; Judit Núñez-Manchón; Alfonsina Ballester-López; Miriam Almendrote; Giuseppe Lucente; Andrea Arbex; Jakub Chojnacki; Rafael P Vázquez-Manrique; Ana Pilar Gómez-Escribano; Guillem Pintos-Morell; Jaume Coll-Cantí; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Mònica Suelves; Gisela Nogales-Gadea
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

Review 9.  Myotonic Dystrophies: A Genetic Overview.

Authors:  Payam Soltanzadeh
Journal:  Genes (Basel)       Date:  2022-02-17       Impact factor: 4.096

10.  Robust Detection of Somatic Mosaicism and Repeat Interruptions by Long-Read Targeted Sequencing in Myotonic Dystrophy Type 1.

Authors:  Antoine Mangin; Laure de Pontual; Yu-Chih Tsai; Laetitia Monteil; Mathilde Nizon; Pierre Boisseau; Sandra Mercier; Janet Ziegle; John Harting; Cheryl Heiner; Geneviève Gourdon; Stéphanie Tomé
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.